Ophthalmology Devices
The U.S. ophthalmology device market is experiencing strong growth due to an aging population, rising vision disorders, and advances in surgical and diagnostic technologies. Our research delivers valuable insights into market trends, product innovation, competitive analysis, and future industry developments.
The U.S. Dry Eye Treatment Devices Market is projected to grow from USD 0.94 billion in 2025 to USD 2.79 billion by 2035 at an 11.49% CAGR, driven by MGD treatment, thermal pulsation, IPL, RF, and neurostimulation adoption.
Read Report Details
The U.S. Age-Related Macular Degeneration Diagnostic Devices Market is projected to grow from USD 0.62 billion in 2025 to USD 1.74 billion by 2035, driven by OCT adoption, multimodal retinal imaging, AI-assisted diagnostics, geographic atrophy monitoring, and home OCT innovation.
Read Report Details
The U.S. Diabetic Retinopathy Screening Devices Market is projected to grow from USD 0.69 billion in 2025 to USD 2.45 billion by 2035 at a 13.50% CAGR, driven by autonomous AI screening, portable retinal imaging, teleophthalmology, and expansion into primary care.
Read Report Details
The U.S. Retinal Disease Diagnostic Devices Market is projected to grow from USD 1.75 billion in 2025 to USD 4.62 billion by 2035 at a 10.20% CAGR, supported by rising OCT adoption, AI-enabled retinal screening, multimodal imaging, and expanding retinal disease monitoring.
Read Report Details
The U.S. Glaucoma Devices Market is projected to grow from USD 2.08 billion in 2025 to USD 5.42 billion by 2035 at a 10.05% CAGR, driven by MIGS adoption, earlier laser intervention, advanced glaucoma diagnostics, and expanding outpatient ophthalmology procedures.
Read Report Details
The U.S. Cataract Surgery Devices Market is projected to grow from USD 2.86 billion in 2025 to USD 6.04 billion by 2035 at a 7.76% CAGR, driven by rising cataract procedure volumes, premium IOL adoption, advanced phaco systems, aging demographics, and ASC-based surgical expansion.
Read Report Details
The U.S. Ophthalmic Therapeutic Devices Market is projected to rise from USD 8.38 billion in 2025 to USD 18.34 billion by 2035, driven by cataract surgery, glaucoma intervention, retinal procedures, premium IOL adoption, and advanced ophthalmic surgical technologies.
Read Report Details
The U.S. Ophthalmic Imaging Devices Market is projected to rise from USD 0.98 billion in 2025 to USD 2.75 billion by 2035 at a 10.87% CAGR, supported by OCT upgrades, AI-enabled diagnostics, retinal disease burden and expanding ophthalmic imaging workflows.
Read Report Details
The U.S. Ophthalmic Surgical Devices Market is projected to grow from USD 7.01 billion in 2025 to USD 14.25 billion by 2035 at a 7.35% CAGR, driven by cataract surgery volumes, premium IOL adoption, MIGS expansion, vitreoretinal innovation, and ASC-based ophthalmic procedures.
Read Report Details
The U.S. Ophthalmic Diagnostic Devices Market is projected to grow from USD 1.06 billion in 2025 to USD 1.97 billion by 2035 at a 6.41% CAGR, driven by OCT adoption, retinal imaging, glaucoma diagnostics, cataract assessment, AI-enabled workflows, and rising age-related eye disease burden.
Read Report Details